Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis

  • Treatment of experimental allergic neuritis with selective immune deviation
  • C. Ekerfelt, C. Dahle, R. Weissert, M. Kvarnström, T. Olsson, J. Ernerudh
  • Clinical & Experimental Immunology, January 2001, Wiley
  • DOI: 10.1046/j.1365-2249.2001.01424.x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Robert Weissert